Efficacy and Safety of Pertuzumab and Trastuzumab Administered in a Single Infusion Bag, Followed by Vinorelbine: VELVET Cohort 2 Final Results. (Record no. 27256614)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01450 a2200385 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517160054.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201806s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1549-490X |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1634/theoncologist.2017-0079 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Andersson, Michael |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20180608 |
245 00 - TITLE STATEMENT | |
Title | Efficacy and Safety of Pertuzumab and Trastuzumab Administered in a Single Infusion Bag, Followed by Vinorelbine: VELVET Cohort 2 Final Results. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The oncologist |
Date of publication, distribution, etc. | 10 2017 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1160-1168 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Breast Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Trastuzumab |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vinblastine |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vinorelbine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | López-Vega, José M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Petit, Thierry |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zamagni, Claudio |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Easton, Valerie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kamber, Julia |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Restuccia, Eleonora |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Perez, Edith A |
773 0# - HOST ITEM ENTRY | |
Title | The oncologist |
Related parts | vol. 22 |
-- | no. 10 |
-- | p. 1160-1168 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1634/theoncologist.2017-0079">https://doi.org/10.1634/theoncologist.2017-0079</a> |
Public note | Available from publisher's website |
No items available.